Cramer, Nathan P <br/><br/>
GABAB-GIRK2-mediated signaling in Down syndrome.  [electronic resource] 

 -  Advances in pharmacology (San Diego, Calif.)  2010 
 - 397-426 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1557-8925 
<br/><br/><label>Standard No.: </label>10.1016/S1054-3589(10)58015-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cognition Disorders--complications<br/>Down Syndrome--complications<br/>G Protein-Coupled Inwardly-Rectifying Potassium Channels--metabolism<br/>Hippocampus--metabolism<br/>Humans<br/>Receptors, GABA-B--metabolism<br/>Signal Transduction